CORRESP Filing
AETHLON MEDICAL INC
Date: Aug. 29, 2025 · CIK: 0000882291 · Accession: 0001683168-25-006557
AI Filing Summary & Sentiment
File numbers found in text: 333-289745
Show Raw Text
CORRESP 1 filename1.htm MAXIM GROUP LLC 300 Park Avenue, 16 th Floor New York, New York 10022 August 29, 2025 VIA EDGAR CORRESPONDENCE U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Aethlon Medical, Inc. Registration Statement on Form S-1, as amended File No. 333-289745 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), we, the underwriter, hereby request that the Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced registration statement on Form S-1 (the "Registration Statement") to become effective at 5:01 p.m., Eastern time, on Tuesday, September 2, 2025, or as soon thereafter as practicable. Pursuant to Rule 460 under the Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus dated August 29, 2025 to agents, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus. The undersigned, as underwriter, has complied and will comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. If you require any additional information with respect to this letter, please contact M. Ali Panjwani at (212) 326-0820 of Pryor Cashman LLP. Very truly yours, MAXIM GROUP LLC By: /s/ Ritesh M. Veera Ritesh M. Veera Co-Head of Investment Banking cc: M. Ali Panjwani, Esq. Pryor Cashman LLP